Last reviewed · How we verify

NCT06635200

Pain Phenotype in Patients With Carpal Tunnel Syndrome

Completed Last updated 25 March 2025
What this trial tests

trial in Carpal Tunnel Syndrome in 113 participants. Completed in 20 March 2025.

Timeline
5 November 2024
Primary endpoint
18 March 2025
20 March 2025

Quick facts

Lead sponsorKutahya Health Sciences University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment113
Start date5 November 2024
Primary completion18 March 2025
Estimated completion20 March 2025
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Kutahya Health Sciences University

Who can join

Adults 18 to 65, any sex, with Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to determine the dominant pain phenotype in a group of patients with Carpal Tunnel Syndrome by applying the International Association for the Study of Pain (IASP) criteria.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

Other Kutahya Health Sciences University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06635200.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing